Evidence map›Paper›PMID 41803462›Full record

ArticleActa pharmacologica Sinica2026

Correction: Berberine attenuates ischemia reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation.

Jun-Rong Zhu, Hai-Dan Lu, Chao Guo, Wei-Rong Fang, Hong-Dong Zhao, Jun-Shan Zhou, Feng Wang, Yan-Li Zhao, Yun-Man Li, Ying-Dong Zhang and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmacologica Sinica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Jun-Rong Zhu *School of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.
Hai-Dan Lu *School of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.
Chao Guo *Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xian, 710032, China.
Wei-Rong FangSchool of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.
Hong-Dong ZhaoDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Jun-Shan ZhouDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Feng WangDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Yan-Li ZhaoSchool of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.
Yun-Man LiSchool of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.
Ying-Dong ZhangSchool of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. zhangyingdong@aliyun.com.
Chang-Qing YangSchool of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. 1020102186@cpu.edu.cn.
Jian-Guo SunDrug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China. jgsun@cpu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41803462
PMCPMC13389052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.